News Conference News ACC 2019 Myocardial Injury Often Miscoded as Type 2 MI L.A. McKeown April 02, 2019
News Conference News ACC 2019 Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY Yael L. Maxwell March 27, 2019
News Conference News ACC 2019 Sonothrombolysis for Acute STEMI? High-Frequency Microbubbles Show Promise in MRUSMI L.A. McKeown March 27, 2019
News Conference News ACC 2019 Time and Money: PCI Public Reporting Requirements Take Their Toll Michael O'Riordan March 26, 2019
News Conference News ACC 2019 First Ticagrelor Reversal Agent Shows Quick Onset, Long Duration in Early Results Yael L. Maxwell March 25, 2019
News Conference News ACC 2019 High Rate of Residual Ischemia After PCI Despite Excellent Angiographic Outcomes: DEFINE-PCI Michael O'Riordan March 21, 2019
News Conference News ACC 2019 No TREAT for Ticagrelor at 12 Months: Fibrinolysis Patients After STEMI Do Just as Well on Clopidogrel Shelley Wood March 19, 2019
Presentation ACC 2019 The SAfety and Efficacy of Femoral Access vs RadIal Access in STEMI: The SAFARI-STEMI Trial Presenter: Michel R Le May March 19, 2019
News Conference News ACC 2019 SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI Michael O'Riordan March 18, 2019
Presentation ACC 2019 Apixaban vs VKA and Aspirin vs Placebo in Patients with Atrial Fibrillation and ACS/PCI: The AUGUSTUS Trial Presenter: Renato Lopes March 18, 2019
News Conference News ACC 2019 Dropping Aspirin: Two Trials Explore P2Y12 Monotherapy After Short-term DAPT Post-PCI Yael L. Maxwell March 18, 2019
News Conference News ACC 2019 Info Gleaned From FFRCT Has Durable Impact on 1-Year Outcomes: ADVANCE Registry Caitlin E. Cox March 18, 2019
News Conference News ACC 2019 COACT: Delayed Angiography Does Not Compromise Survival in Cardiac Arrest Patients Without STEMI L.A. McKeown March 18, 2019
News Conference News ACC 2019 AUGUSTUS: Apixaban Plus P2Y12 Inhibitor the Best Combo in A-fib Patients With ACS or Undergoing PCI Caitlin E. Cox March 17, 2019
Presentation ACC 2019 Initiation of Angiotensin-Neprilysin Inhibition after Acute Decompensated Heart Failure: Results of the Open-Label Extension of the PIONEER-HF Trial Presenter: Adam D. DeVore March 17, 2019
News Conference News ACC 2019 Spectrum of Shock Treated in Contemporary US Practice: Clues From the CCCTN Caitlin E. Cox March 16, 2019
News Conference News ACC 2019 ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend Shelley Wood March 11, 2019
News Conference News ACC 2019 Under 40, or 10 Years Older: MI Survivors Face Similar Long-term Mortality Risks Todd Neale March 07, 2019